The University of Chicago Header Logo

Connection

Jerry Krishnan to Bronchodilator Agents

This is a "connection" page, showing publications Jerry Krishnan has written about Bronchodilator Agents.
Connection Strength

1.723
  1. Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. N Engl J Med. 2022 09 29; 387(13):1173-1184.
    View in: PubMed
    Score: 0.205
  2. Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021 12; 5(12):862-872.
    View in: PubMed
    Score: 0.193
  3. Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 05 01; 201(9):e56-e69.
    View in: PubMed
    Score: 0.174
  4. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. Int J Chron Obstruct Pulmon Dis. 2019; 14:2927-2938.
    View in: PubMed
    Score: 0.170
  5. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med. 2019 09 26; 381(13):1227-1239.
    View in: PubMed
    Score: 0.167
  6. Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. N Engl J Med. 2019 05 23; 380(21):2009-2019.
    View in: PubMed
    Score: 0.163
  7. Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma. JAMA. 2018 04 10; 319(14):1441-1443.
    View in: PubMed
    Score: 0.151
  8. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2009 Aug 10; 169(15):1403-10.
    View in: PubMed
    Score: 0.083
  9. Real-world treatment trajectories of adults with newly diagnosed asthma or COPD. BMJ Open Respir Res. 2024 02 27; 11(1).
    View in: PubMed
    Score: 0.057
  10. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma. Am J Respir Crit Care Med. 2023 02 15; 207(4):390-405.
    View in: PubMed
    Score: 0.053
  11. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023 03; 163(3):502-514.
    View in: PubMed
    Score: 0.052
  12. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2022 09 01; 206(5):554-562.
    View in: PubMed
    Score: 0.051
  13. A Practical Guide to Implementing SMART in Asthma Management. J Allergy Clin Immunol Pract. 2022 01; 10(1S):S31-S38.
    View in: PubMed
    Score: 0.048
  14. GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J. 2019 Jun; 53(6).
    View in: PubMed
    Score: 0.041
  15. Poor Metered-Dose Inhaler Technique Is Associated with Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2019 06; 16(6):765-768.
    View in: PubMed
    Score: 0.041
  16. Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS. Ann Am Thorac Soc. 2019 02; 16(2):200-208.
    View in: PubMed
    Score: 0.040
  17. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 03; 49(3).
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.